Xcout Intel
FundaMental Pharma competitors & alternatives
The 12 closest competitors and alternatives to FundaMental Pharma among drug discovery companies — ranked by similarity to what FundaMental Pharma actually does, not by market-cap band.
Subscribe to see FundaMental Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About FundaMental Pharma
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
FundaMental Pharma at a glance
FundaMental Pharma is a drug discovery company headquartered in Germany. Its most recent funding round, Seed, raised $3M in April 2024. Xcout tracks 18 named people at FundaMental Pharma, including Dirk Beher (CEO).
FundaMental Pharma leadership
- Dirk BeherCEO
- Hans ErikssonChief Medical Officer
- Keno GutierrezChairman of the Board
- Hilmar BadingScientific Founder
- Alexander StraubHead of Chemistry
- Colin KahrsHead of Intellectual Property
12 more named people on record for FundaMental Pharma, with roles, board committees and tenure — see the full roster →
FundaMental Pharma funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3M | 4 named | |
| Seed | $13.8M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 FundaMental Pharma competitors
Ranked by semantic similarity — how close each company is to FundaMental Pharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Similar drug discovery company
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
Similar drug discovery company
Object Pharma is a privately held biopharmaceutical company headquartered in Aliso Viejo, California, founded in 2018. The company is dedicated to developing novel treatments for mental health disorders and manufactures botulinum toxin products for accredited research use.
Similar drug discovery company
Neurasic Therapeutics is a Montreal-based drug discovery company founded in 2020 and based on research from McGill University's Montreal Neurological Institute. The company develops therapeutic solutions and medicinal drugs aimed at treating neurological disorders, with a primary focus on advancing opiate-sparing, pain-relieving treatments such as substituted thiophene for neuropathic and inflammatory pain.
Similar drug discovery company
Kupando is a pioneering Berlin-based biopharmaceutical and biotech company headquartered in Schönefeld, Germany. The company is focused on the research and clinical development of innovative treatments to fight cancer and infectious diseases.
Similar drug discovery company
Stellate Therapeutics is a pre-clinical stage biotechnology company that develops small molecules produced by human gut bacteria into therapies for neurodegenerative and age-related neurological diseases.
Similar drug discovery company
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Similar drug discovery company
Kinoxis Therapeutics Pty Ltd is an Australian-based, clinical-stage biotechnology company that develops first-in-class therapeutics targeting ALOX15 to address central nervous system (CNS) diseases.
Similar drug discovery company
Retrotope, Inc. is a drug development company headquartered in Los Altos, California, focused on creating therapeutics for degenerative diseases.
Similar drug discovery company
Versameb AG is a privately held biopharmaceutical company focused on discovering and developing innovative RNA-based therapeutics.
Similar drug discovery company
VectorY Therapeutics is a fully integrated gene therapy company founded in August 2020 and based in Amsterdam, Netherlands. The company is focused on developing novel gene therapies, including clinical trials for conditions like amyotrophic lateral sclerosis (ALS).
Medtech
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of FundaMental Pharma and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for FundaMental Pharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →